Dunne Michael W.

Average Profitability
124.28%
Insider Buys Quantity
8
Insider Buys Sum
$211,133.00
Insider Sells Quantity
1
Insider Sells Sum
$57,337.39

Insider Activity of Dunne Michael W.

According to the SEC Form 4 filings, Dunne Michael W., being in a position of

  1. director at Iterum Therapeutics plc,
    оver the last 12 months, has bought 55000 shares for $94,132, and sold 0 shares,
    over all time since 2018-05-30, has bought 185080 shares for $211,133, and sold 33143 shares for $57,337.

The largest purchase of all time was on 2018-05-30 and amounted to 4000 shares of Iterum Therapeutics plc for $52,000.

The largest sale of all time was on 2021-01-26 and amounted to 33143 shares of Iterum Therapeutics plc for $57,337.

Biography of Dunne Michael W.

No biography is available at this moment.

2023-12-22PurchaseIterum Therapeutics plc
ITRM
director
25,000
0.1716%
$1.40$35,000+1.07%
2023-12-18PurchaseIterum Therapeutics plc
ITRM
director
10,000
0.0794%
$1.84$18,442-18.75%
2023-11-22PurchaseIterum Therapeutics plc
ITRM
director
20,000
0.1507%
$2.03$40,690-29.81%
2021-01-26SaleIterum Therapeutics plc
ITRM
director
33,143
0.0299%
$1.73$57,337-49.75%
2020-10-27PurchaseIterum Therapeutics plc
ITRM
Chief Scientific Officer
123,080
0.3428%
$0.33$40,001+124.28%
2018-09-04PurchaseIterum Therapeutics plc
ITRM
Chief Scientific Officer
1,000
0.0038%
$5.00$5,000-30.64%
2018-08-27PurchaseIterum Therapeutics plc
ITRM
Chief Scientific Officer
1,000
0.0071%
$10.00$10,000-34.86%
2018-08-24PurchaseIterum Therapeutics plc
ITRM
Chief Scientific Officer
1,000
0.0071%
$10.00$10,000-34.68%
2018-05-30PurchaseIterum Therapeutics plc
ITRM
Chief Scientific Officer
4,000
0.0604%
$13.00$52,000-40.58%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.